SEC Form 4 · accession 0001127602-15-014532

Elevance Health, Inc. · ELV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Samuel R Nussbaum M.D.

Officer — EVP & Chief Medical Officer

Period of report

Apr 13, 2015

Accepted (ET)

Apr 15, 2015 · 4:12 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156039

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 13, 2015	M	46,667	$76.59	A	157,640	D
Common Stock	Apr 13, 2015	M	2,673	$30.10	A	160,313	D
Common Stock^F2	Apr 13, 2015	S	14,508	$154.29	D	145,805	D
Common Stock^F3	Apr 13, 2015	S	34,832	$155.06	D	110,973	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F4	$76.59	Apr 13, 2015	M	46,667	D	—	Mar 1, 2016	Common Stock	46,667	20,000	D
Employee Stock Option (Right to Buy)^F5	$30.10	Apr 13, 2015	M	2,673	D	—	Mar 2, 2016	Common Stock	2,673	0	D

Explanation of responses

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2015.
F2This transaction was executed in multiple trades at prices ranging from $153.78 to $154.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
F3This transaction was executed in multiple trades at prices ranging from $154.79 to $155.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
F4The option, representing a right to purchase a total of 66,667 shares, became exercisable in five equal semi-annual installments of 11,111 shares each and one semi-annual installment of 11,112 shares beginning on September 1, 2006, which was the six-month anniversary of the date on which the option was granted.
F5The option, representing a right to purchase a total of 92,285 shares, became exercisable in one semi-annual installment of 15,380 shares and five equal semi-annual installments of 15,381 shares each beginning on September 2, 2009, which was the six-month anniversary of the date on which the option was granted.